Clinical Trials Directory

Trials / Completed

CompletedNCT06653608

Clinical Efficacy of Novel Jasminum-based Calcium Hydroxide Medicament

Clinical Efficacy of Novel Jasminum-based Nano-reinforced Calcium Hydroxide Medicament on Postoperative Pain: a Triple-blind Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Pakistan Institute of Medical Sciences · Other Government
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

A triple-blind, parallel group, randomized trial with an allocation ratio of 1:1. Participants randomly allocated into two groups A and B. In group A, nano-reinforced calcium hydroxide medicament was utilized while in group B, calcium hydroxide medicament without nanoparticles was used. Post-operative pain was assessed after 4 hours, 24 hours, 48 hours, 72 hours, 96 hours.

Detailed description

This triple-blind parallel group, randomized clinical trial was conducted at the department of Operative Dentistry and Endodontics, School of Dentistry from April 24, 2024 to September 25, 2024. Participants were randomly distributed into two groups by Lottery method. A consecutive non-probability sampling technique was used. Before initiating treatment, participants were briefed about the intervention and their preoperative pain score was recorded. In both groups, endodontic treatment was initiated under rubber dam isolation. Access opening done and canals explored. Working length taken by radiographic method and reconfirmed by an electronic apex locator. Afterwards, canals were prepared till Master Apical File size F2 (4% Taper). In group A, Nano-reinforced calcium hydroxide medicament was placed while in group B, calcium hydroxide without nanoparticles was utilized. Participants were instructed to rate their postoperative pain record after 4hrs, 24hrs, 48hrs, 72hrs and 96hrs.

Conditions

Interventions

TypeNameDescription
DRUGNano-reinforced calcium hydroxide medicamentGroup A (Calcium hydroxide intracanal medicament reinforced with jasminum derived- titania nanoparticles)
DRUGCalcium hydroxide without nanopariclesGroup B ( Calcium hydroxide medicament without nanoparticles)

Timeline

Start date
2024-04-24
Primary completion
2024-09-25
Completion
2024-09-25
First posted
2024-10-22
Last updated
2024-10-30

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06653608. Inclusion in this directory is not an endorsement.